Cardiovascular diseases (CVDs) have been recognized as first killer of human health. The underlying mechanisms of CVDs are extremely complicated and not fully revealed, leading to a challenge for CVDs treatment in modern medicine. Traditional Chinese medicine (TCM) characterized by multiple compounds and targets has shown its marked effects on CVDs therapy. However, system-level understanding of the molecular mechanisms is still ambiguous. In this study, a system pharmacology approach was developed to reveal the underlying molecular mechanisms of a clinically effective herb formula (Wen-Dan Decoction) in treating CVDs. 127 potential active compounds and their corresponding 283 direct targets were identified in Wen-Dan Decoction. The networks among active compounds, targets, and diseases were built to reveal the pharmacological mechanisms of Wen-Dan Decoction. A "CVDs pathway" consisted of several regulatory modules participating in therapeutic effects of Wen-Dan Decoction in CVDs. All the data demonstrates that Wen-Dan Decoction has multiscale beneficial activity in CVDs treatment, which provides a new way for uncovering the molecular mechanisms and new evidence for clinical application of Wen-Dan Decoction in cardiovascular disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971304PMC
http://dx.doi.org/10.1155/2018/5170854DOI Listing

Publication Analysis

Top Keywords

wen-dan decoction
28
molecular mechanisms
12
traditional chinese
8
chinese medicine
8
cardiovascular diseases
8
cvds treatment
8
compounds targets
8
active compounds
8
wen-dan
7
decoction
7

Similar Publications

Objective: Schizophrenia (SCZ) is a prevalent chronic mental disorder characterized by a high recurrence rate and significant disability. Currently, no satisfactory pharmacological treatments have been identified. Although Ningshen Wendan decoction (NSWDD) has shown promising results in improving cognitive function in patients with schizophrenia, its underlying mechanism of action remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on Huanglian Wendan (HLWD), a traditional Chinese medicine, to treat metabolic-associated fatty liver disease (MAFLD) and atherosclerosis, both common health issues that often occur together.
  • Researchers aimed to identify the effective compounds in HLWD and understand how they work against MAFLD and atherosclerosis, using advanced techniques like ultrahigh-performance liquid chromatography and network analysis.
  • The results revealed 18 active components in HLWD and demonstrated that it effectively improves liver health and reduces body weight and blood lipids in a mouse model of MAFLD and atherosclerosis.
View Article and Find Full Text PDF

Coronary heart disease is a common cardiovascular disease, attacking about 11.4 million patients in China. With increasing prevalence and mortality year by year, coronary heart disease has become a major factor threatening human health and public health.

View Article and Find Full Text PDF

Insomnia is a typical type of sleep disorder. Huanglian Wendan Decoction (HWD) is a traditional Chinese medicine (TCM) with the effects of regulating Qi, drying dampness and resolving phlegm, calming the mind, and relieving irritation. This study aims to investigate the effect of HWD on insomnia in rats and its mechanism.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!